Acasti Pharma reported $20K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Addus HomeCare USD 144.82M 6.87M Mar/2026
Amarin USD 126.83M 477K Dec/2025
Cassava Sciences USD 120K 697K Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Option Care Health USD 516.44M 42.87M Mar/2026
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Tilray USD 109.07M 2M Sep/2025